Degenerative diseases of the lumbar spine M00-M99
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Degenerative diseases of the lumbar spine (L1-S1) one or two sections affected
Exclusion criteria
Exclusion criteria: Systemic diseases (e.g. rheumatic spectrum disorder including Bechterews disease, infectious diseases including HIV, tumor diseases, etc.)- Systemic intake of gulucocorticoides or immunosuppressants- Postoperative regular intake of NSAID in the first 6 month- Osteoporosis (T-Score < -2,5)- Fracture- Infection of the spine- Previous operation of the lumbar spine excepting nucleotomy and decompression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The introduced clinical trial shall analyse if the use of titanium coated PEEK cages brings advantages in terms of an early osseous incorporation and a higher fusion rate as opposed to a pure PEEK cage. We will do an x-ray preOP, postOP and after 3, 6, and 12 month, also an CT after 6 and 12month. If the Fusion is not adequate at this point, an other CT will be done 24 month after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| In contrast the clinical outcome and the complication rate should not be different if different PEEK cages are used. These information will be registered with help of different questionnaires preOP, postOP and after 3, 6, and 12 month. We use VAS (Backpain), EQ-5D (measure of health status), Oswestry Disability Index (rating the severity of back pain) and Odoms Criteria (improvement of symptoms after surgery). | — |
Countries
Germany
Contacts
Berufsgenossenschaftliche Unfallklinik Frankfurt, Zentrum für Wirbelsäulenchirurgie und Neurotraumatologie